Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dyslipidemia

Free Subscription Articles published in Curr Opin Lipidol Retrieve available abstracts of 35 articles: HTML format

Single Articles

June 2025
1. PRAKASH Y, Bhatt DL, Malick WA
   Emerging agents targeting triglycerides.
   Curr Opin Lipidol. 2025;36:119-129.
   PubMed     Abstract available
   
   
   April 2025
2. TADA H, Nohara A, Kawashiri MA, Takamura M, et al
   Impact of Achilles tendon on diagnosis and phenotypes of familial hypercholesterolemia.
   Curr Opin Lipidol. 2025 Apr 14. doi: 10.1097/MOL.0000000000000992.
   PubMed     Abstract available
   
   
   
3. HEGELE RA
   What is the phenotype of heterozygous lipoprotein lipase deficiency?
   Curr Opin Lipidol. 2025;36:96-103.
   PubMed     Abstract available
   
   
   
4. ISON HE, Helm B, Kringlen G, Crawford P, et al
   Navigating variants of uncertain significance in genetic dyslipidemia: how to assess and counsel patients.
   Curr Opin Lipidol. 2025;36:49-54.
   PubMed     Abstract available
   
   
   March 2025
5. ALNOURI F, Raal FJ
   Familial hypercholesterolemia in pregnancy.
   Curr Opin Lipidol. 2025 Mar 7. doi: 10.1097/MOL.0000000000000980.
   PubMed     Abstract available
   
   
   December 2024
6. TAMEHRI ZADEH SS, Pang J, Chan DC, Watts GF, et al
   A contemporary snapshot of familial hypercholesterolemia registries.
   Curr Opin Lipidol. 2024;35:297-302.
   PubMed     Abstract available
   
   
   November 2024
7. BIRKENHEAD K, Sullivan D, Watts GF, Sarkies MN, et al
   Implementation science and genetic testing for familial hypercholesterolemia.
   Curr Opin Lipidol. 2024 Nov 26. doi: 10.1097/MOL.0000000000000967.
   PubMed     Abstract available
   
   
   
8. PAQUETTE M, Guay SP, Baass A
   Genetic determinants of pancreatitis risk in hypertriglyceridemia.
   Curr Opin Lipidol. 2024 Nov 11. doi: 10.1097/MOL.0000000000000962.
   PubMed     Abstract available
   
   
   September 2024
9. RAMASWAMI U, Priestley-Barnham L, Humphries SE
   Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families.
   Curr Opin Lipidol. 2024 Sep 27. doi: 10.1097/MOL.0000000000000952.
   PubMed     Abstract available
   
   
   August 2024
10. FOSTER C, Gagnon CA, Ashraf AP
    Altered lipid metabolism and the development of metabolic-associated fatty liver disease.
    Curr Opin Lipidol. 2024;35:200-207.
    PubMed     Abstract available
    
    
    June 2024
11. BASHIR B, Ferdousi M, Durrington PN, Soran H, et al
    Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia.
    Curr Opin Lipidol. 2024 Jun 7. doi: 10.1097/MOL.0000000000000939.
    PubMed     Abstract available
    
    
    
12. MULDER JWCM, Kusters DM, Roeters van Lennep JE, Hutten BA, et al
    Lipid metabolism during pregnancy: consequences for mother and child.
    Curr Opin Lipidol. 2024;35:133-140.
    PubMed     Abstract available
    
    
    April 2024
13. BRUNHAM LR
    Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?
    Curr Opin Lipidol. 2024 Apr 22. doi: 10.1097/MOL.0000000000000938.
    PubMed     Abstract available
    
    
    
14. CIVEIRA F, Martin C, Cenarro A
    APOE and familial hypercholesterolemia.
    Curr Opin Lipidol. 2024 Apr 17. doi: 10.1097/MOL.0000000000000937.
    PubMed     Abstract available
    
    
    
15. RASMUSSEN KL, Frikke-Schmidt R
    The current state of apolipoprotein E in dyslipidemia.
    Curr Opin Lipidol. 2024;35:78-84.
    PubMed     Abstract available
    
    
    
16. WEN Y, Chen YQ, Konrad RJ
    Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism.
    Curr Opin Lipidol. 2024;35:58-65.
    PubMed     Abstract available
    
    
    February 2024
17. CHAN DC, Watts GF
    ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?
    Curr Opin Lipidol. 2024 Feb 20. doi: 10.1097/MOL.0000000000000920.
    PubMed     Abstract available
    
    
    
18. VAN DEN BOSCH SE, Hutten BA, Corpeleijn WE, Kusters DM, et al
    Familial hypercholesterolemia in children and the importance of early treatment.
    Curr Opin Lipidol. 2024 Feb 15. doi: 10.1097/MOL.0000000000000926.
    PubMed     Abstract available
    
    
    
19. PAPONJA K, Pecin I, Reiner Z, Banach M, et al
    Bempedoic acid: new evidence and recommendations on use.
    Curr Opin Lipidol. 2024;35:41-50.
    PubMed     Abstract available
    
    
    
20. ZHANG Y, de Ferranti SD, Moran AE
    Genetic testing for familial hypercholesterolemia.
    Curr Opin Lipidol. 2024 Feb 1. doi: 10.1097/MOL.0000000000000925.
    PubMed     Abstract available
    
    
    December 2023
21. PERERA SD, Hegele RA
    Genetic variation in apolipoprotein A-V in hypertriglyceridemia.
    Curr Opin Lipidol. 2023 Dec 21. doi: 10.1097/MOL.0000000000000916.
    PubMed     Abstract available
    
    
    
22. ROMERO-JIMENEZ MJ, Mansilla-Rodriguez ME, Gutierrez-Cortizo EN
    Predictors of cardiovascular risk in familial hypercholesterolemia.
    Curr Opin Lipidol. 2023;34:272-277.
    PubMed     Abstract available
    
    
    
23. GILLARD BK, Rosales C, Gotto AM Jr, Pownall HJ, et al
    The pathophysiology of excess plasma-free cholesterol.
    Curr Opin Lipidol. 2023;34:278-286.
    PubMed     Abstract available
    
    
    
24. KARALIS DG
    Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular disease.
    Curr Opin Lipidol. 2023;34:252-258.
    PubMed     Abstract available
    
    
    November 2023
25. ROY G, Drouin-Chartier JP
    Cardiovascular disease prevention in heterozygous familial hypercholesterolemia: how important is a healthy diet in the era of long-lasting cholesterol-lowering drug therapies?
    Curr Opin Lipidol. 2023 Nov 2. doi: 10.1097/MOL.0000000000000908.
    PubMed     Abstract available
    
    
    October 2023
26. CHATTOPADHYAY A, Reddy ST, Fogelman AM
    The multiple roles of lysophosphatidic acid in vascular disease and atherosclerosis.
    Curr Opin Lipidol. 2023;34:196-200.
    PubMed     Abstract available
    
    
    August 2023
27. CHOUDHARI P, Patni N
    Updates in the management of pediatric dyslipidemia.
    Curr Opin Lipidol. 2023;34:156-161.
    PubMed     Abstract available
    
    
    June 2023
28. GANDA OP
    Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease.
    Curr Opin Lipidol. 2023;34:105-113.
    PubMed     Abstract available
    
    
    
29. WADSTROM BN, Pedersen KM, Wulff AB, Nordestgaard BG, et al
    Inflammation compared to low-density lipoprotein cholesterol: two different causes of atherosclerotic cardiovascular disease.
    Curr Opin Lipidol. 2023;34:96-104.
    PubMed     Abstract available
    
    
    April 2023
30. CLARKE SL
    Does low-density lipoprotein fully explain atherosclerotic risk in familial hypercholesterolemia?
    Curr Opin Lipidol. 2023;34:52-58.
    PubMed     Abstract available
    
    
    
31. HEGELE RA
    DNA testing in dyslipidemia: attitudes and complexities.
    Curr Opin Lipidol. 2023;34:33-34.
    PubMed    
    
    
    March 2023
32. VUORIO A, Raal F, Kovanen PT
    Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-19.
    Curr Opin Lipidol. 2023 Mar 10. doi: 10.1097/MOL.0000000000000876.
    PubMed     Abstract available
    
    
    February 2023
33. HANG SMT, Hegele RA, Berberich AJ
    Genetic determinants of pancreatitis: relevance in severe hypertriglyceridemia.
    Curr Opin Lipidol. 2023 Feb 2. doi: 10.1097/MOL.0000000000000866.
    PubMed     Abstract available
    
    
    January 2023
34. REIJMAN MD, Defesche JC, Wiegman A
    Genotype-phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia.
    Curr Opin Lipidol. 2023 Jan 18. doi: 10.1097/MOL.0000000000000863.
    PubMed     Abstract available
    
    
    December 2022
35. DRON JS
    The clinical utility of polygenic risk scores for combined hyperlipidemia.
    Curr Opin Lipidol. 2022 Dec 28. doi: 10.1097/MOL.0000000000000865.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.